Lung non-small cell squamous carcinoma
Clinical trials for Lung non-small cell squamous carcinoma explained in plain language.
Never miss a new study
Get alerted when new Lung non-small cell squamous carcinoma trials appear
Sign up with your email to follow new studies for Lung non-small cell squamous carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for tough lung cancer
Disease control OngoingThis study tests a combination of drugs (berzosertib, carboplatin, gemcitabine, and pembrolizumab) in people with advanced squamous non-small cell lung cancer that has spread. The goal is to find the best dose and see if the combo helps control the cancer longer than standard tre…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 21, 2026 15:00 UTC
-
New combo therapy shows promise for early lung cancer
Disease control OngoingThis study tests whether adding an immunotherapy drug (nivolumab) to precise, high-dose radiation therapy helps prevent lung cancer from coming back in people with early-stage non-small cell lung cancer. About 140 participants will receive either radiation alone or radiation plus…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC